No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RVTY Revvity
- 109.870
- -3.510-3.10%
Close Jul 18 16:00 ET
- 109.870
- 0.0000.00%
Post 17:03 ET
13.56BMarket Cap87.20P/E (TTM)
113.740High109.405Low873.28KVolume111.860Open113.380Pre Close97.21MTurnover0.76%Turnover Ratio19.80P/E (Static)123.39MShares131.60452wk High1.73P/B12.61BFloat Cap79.34052wk Low0.28Dividend TTM114.76MShs Float201.902Historical High0.25%Div YieldTTM3.82%Amplitude3.484Historical Low111.310Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Revvity Inc : Bernstein Cuts Target Price to $121 From $123
Revvity To Go Ex-Dividend On July 19th, 2024 With 0.07 USD Dividend Per Share
July 17th (Eastern Time) - $Revvity(RVTY.US)$ is trading ex-dividend on July 19th, 2024.Shareholders of record on July 19th, 2024 will receive 0.07 USD dividend per share on August 9th, 2024. The ex-
NIH Outlays Rise by 5% in June, Says Baird
Revvity To Hold Earnings Call on Monday, July 29, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it will release its second quarter 2024 financial results prior to market open on Monday, July 29, 2024. The Company
Leerink Partners Initiates Revvity(RVTY.US) With Buy Rating, Announces Target Price $125
Leerink Partners analyst Puneet Souda initiates coverage on $Revvity(RVTY.US)$ with a buy rating, and sets the target price at $125.According to TipRanks data, the analyst has a success rate of 32.2%
Revvity Price Target Announced at $125.00/Share by Leerink Partners
Revvity Price Target Announced at $125.00/Share by Leerink Partners
Comments
The stock appears overpriced with high beta causing amplified price movements. Despite Revvity's positive outlook, the current price surpasses industry peers, suggesting caution before investing.
Is It Too Late To Consider Buying Revvity, Inc. (NYSE:RVTY)?Despite Revvity's promising earnings outlook, its costly stock could spur selling by shareholders and deter potential investors. It's advised to await a price dip before investing.
The company's management pointed to a decrease in demand from its pharma and biotech customers, leading to a revenue decline in its life sciences business.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg